Prothena Corporation Announces Resignation of Chief Development Officer
PUBLIC · PRTAOct 02, 2026
Position
Chief Development Officer
Company
Prothena Corporation
Chad J. Swanson, Ph.D.
DublinBiotechnologyHealth CareTherapeutics
Description
On October 2, 2026, Prothena Corporation announced the resignation of Chad J. Swanson, Ph.D., who served as the Chief Development Officer. His resignation will take effect on October 9, 2026, as he transitions to a leadership role with one of the company's strategic partners
Company Information
Company
Prothena Corporation
Location
Dublin, Dublin, Ireland
About
Prothena Corporation plc is a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise. The company is focused on advancing a promising pipeline in neurodegenerative and rare peripheral amyloid diseases, guided by patient-focused drug development.
Fundz sees it the moment Prothena Corporation changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.